Congratulations to the incoming class of Nephrology fellows! I’m one of you! I went to way too many interviews and had the pleasure of meeting several passionate nephrologists and fellows. I’m confident that there are a lot of…
Nephrology fellows – you don’t want to miss the Siegfried & Roy of Billing & Coding @ParinMakadia @drirfanagha at Nephrology Business Leadership 2018 https://t.co/2GtrF6hBCM @NBLUniv @Nephro_Sparks @DiMiRenalMD @DallasRenal pic.twitter.com/XaD2gmuJ1U — Samir Nangia MD CPE (@SamirNangia) January 19, 2018…
The PRESERVE Trial, which was recently published in the NEJM was a large study of a variety of preventive measures for contrast-induced nephropathy. It used a 2×2 factorial design to test the efficacy of NaHCO3 vs. normal saline…
The next session of GlomCon’s Nephropathology Essentials will be held this Tuesday, June 12th at 11 am EDT. Dr. Helmut Rennke will be leading the session which will focus on Minimal Change Disease and FSGS (see below for…
One of the things that I always highlight when teaching fellows and residents is the importance of appropriate drug dosing for patients on dialysis and one of the drugs that is most often inappropriately dosed in my experience…
The goal of the GlomCon Teaching Platform is to enable Nephrologists, Nephropathologists, and trainees in Medicine, Nephrology, and Pathology to connect with each other to 1) Discuss challenging cases, 2) Share clinical experiences and 3) Obtain the expertise of participating…
Recently the FDA approved one of the newer exchange resins (Lokelma, ZS-9) for the treatment of hyperkalemia. (Veltassa, Patiromer), a calcium based cation exchange resin, was recently developed and approved since 2015 for the treatment of hyperkalemia. These…
As part of an effort to organize some materials relevant to career development for budding physician-scientists in my division, I wrote the following letter and deposited it on a shared drive. Since it might be helpful to other…
Hydroxocobalamin is an antidote that was recently approved by the FDA in 2006 for the treatment of cyanide poisoning. For decades, cyanide poisoning has historically been treated using the cyanide antidote kit that contained a concoction of amyl…
Donor specific Antibodies (DSA) are one of the established biomarkers for predicting antibody mediated rejection (ABMR). This blog is a short synopsis on DSA and their complex characteristics in kidney transplantation. DSA may be preformed (before transplantation) or de-novo…